Literature DB >> 25728958

End-of-life management in patients with amyotrophic lateral sclerosis.

Sheelah Connolly1, Miriam Galvin2, Orla Hardiman3.   

Abstract

Most health-care professionals are trained to promote and maintain life and often have difficulty when faced with the often rapid decline and death of people with terminal illnesses such as amyotrophic lateral sclerosis (ALS). By contrast, data suggest that early and open discussion of end-of-life issues with patients and families allows time for reflection and planning, can obviate the introduction of unwanted interventions or procedures, can provide reassurance, and can alleviate fear. Patients' perspectives regarding end-of-life interventions and use of technologies might differ from those of the health professionals involved in their care, and health-care professionals should recognise this and respect the patient's autonomy. Advance care directives can preserve autonomy, but their legal validity and use varies between countries. Clinical management of the end of life should aim to maximise quality of life of both the patient and caregiver and, when possible, incorporate appropriate palliation of distressing physical, psychosocial, and existential distress. Training of health-care professionals should include the development of communication skills that help to sensitively manage the inevitability of death. The emotional burden for health-care professionals caring for people with terminal neurological disease should be recognised, with structures and procedures developed to address compassion, fatigue, and the moral and ethical challenges related to providing end-of-life care.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25728958     DOI: 10.1016/S1474-4422(14)70221-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  40 in total

1.  Radiotherapy treatment of the salivary glands, sialorrhea, and non-invasive mechanical ventilation in amyotrophic lateral sclerosis: what are we doing?

Authors:  Giancarlo Garuti; Jessica Mandrioli; Antonio M Esquinas
Journal:  J Neurol       Date:  2016-01-02       Impact factor: 4.849

Review 2.  Neurologists as primary palliative care providers: Communication and practice approaches.

Authors:  Claire J Creutzfeldt; Maisha T Robinson; Robert G Holloway
Journal:  Neurol Clin Pract       Date:  2016-02

3.  Ethical challenges in tracheostomy-assisted ventilation in amyotrophic lateral sclerosis.

Authors:  Morten Magelssen; Trygve Holmøy; Morten Andreas Horn; Ove Arne Fondenæs; Knut Dybwik; Reidun Førde
Journal:  J Neurol       Date:  2018-09-14       Impact factor: 4.849

4.  An eye-tracking controlled neuropsychological battery for cognitive assessment in neurological diseases.

Authors:  Barbara Poletti; Laura Carelli; Federica Solca; Annalisa Lafronza; Elisa Pedroli; Andrea Faini; Stefano Zago; Nicola Ticozzi; Andrea Ciammola; Claudia Morelli; Paolo Meriggi; Pietro Cipresso; Dorothée Lulé; Albert C Ludolph; Giuseppe Riva; Vincenzo Silani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

Review 5.  Supportive and symptomatic management of amyotrophic lateral sclerosis.

Authors:  Esther V Hobson; Christopher J McDermott
Journal:  Nat Rev Neurol       Date:  2016-08-12       Impact factor: 42.937

6.  Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Jürgen Keller; Martin Gorges; Helena E A Aho-Özhan; Ingo Uttner; Erich Schneider; Jan Kassubek; Elmar H Pinkhardt; Albert C Ludolph; Dorothée Lulé
Journal:  J Vis Exp       Date:  2016-10-13       Impact factor: 1.355

7.  Experience matters: neurologists' perspectives on ALS patients' well-being.

Authors:  Helena E A Aho-Özhan; Sarah Böhm; Jürgen Keller; Johannes Dorst; Ingo Uttner; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

8.  Physician perceptions about living organ donation in patients with Amyotrophic Lateral Sclerosis.

Authors:  S Ansari; M B Bromberg; S B Gibson
Journal:  Clin Neurol Neurosurg       Date:  2017-07-05       Impact factor: 1.876

9.  Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications.

Authors:  Peter M Andersen; Magdalena Kuzma-Kozakiewicz; Jürgen Keller; Helena E A Aho-Oezhan; Katarzyna Ciecwierska; Natalia Szejko; Cynthia Vázquez; Sarah Böhm; Gisela Badura-Lotter; Thomas Meyer; Susanne Petri; Katharina Linse; Andreas Hermann; Olof Semb; Erica Stenberg; Simona Nackberg; Johannes Dorst; Ingo Uttner; Ann-Cristin Häggström; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2018-05-04       Impact factor: 4.849

10.  Advance care planning in amyotrophic lateral sclerosis (ALS): study protocol for a qualitative longitudinal study with persons with ALS and their family carers.

Authors:  Isabel Vandenbogaerde; Rose Miranda; Jan L De Bleecker; Emma Carduff; Agnes van der Heide; Lieve Van den Block; Luc Deliens; Aline De Vleminck
Journal:  BMJ Open       Date:  2022-05-12       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.